Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare is expected to experience a decline in Medicaid membership similar to its competitors, but its flat year-over-year enrollment assumptions may be too optimistic, especially with its conservative 2026 guidance. However, the increase in adjusted EPS reflects potential growth in its managed health benefit risks for Medicaid as well as its other reportable segments. Overall, while the stock may be risky to own, the company's financials and market position suggest potential for long-term growth.

Molina Healthcare is facing significant challenges in the near term, including Medicaid rate and acuity mismatch, potential impact from eAPTCs, and difficulty with operational initiatives. Their recent guidance for 2026 is not in line with initial investor expectations, and concerns remain around their optimistic assumptions for Marketplace MLR progression and Medicaid trends. There are also concerns about their margin compression in Medicaid, and they may face further pressure if their MAPD book experiences an exit in 2027. Furthermore, Molina's recent report of lower-than-expected earnings and Medicaid retro items raises concerns about their ability to meet their previously stated targets and manage risk. The company's significant exposure to state Medicaid programs, particularly in California, New York, Texas, and Washington, also poses a potential risk to their financial stability. Additionally, their projected margin for 2026 is significantly lower compared to their peers, and their market share may further decrease if they are unable to effectively integrate acquisitions and win RFPs.